Suppr超能文献

针对与可溶性雌激素受体相关成分的单克隆抗体。

Monoclonal antibodies against a component related to soluble estrogen receptor.

作者信息

Coffer A I, Lewis K M, Brockas A J, King R J

出版信息

Cancer Res. 1985 Aug;45(8):3686-93.

PMID:4016746
Abstract

Mice were immunized with 1 to 3 micrograms of cytoplasmic estrogen receptor fragment purified from human myometrium by affinity chromatography. Two RE-antibody-secreting clones were detected from one fusion that were capable of precipitating cytosol RE. Monoclonal antibody D5 (subclass IgG1) reacts with an antigen that is related to RE from immunoprecipitation studies but which can be separated from the hormone binding unit. In the presence of anti-mouse serum, D5 precipitates labeled human cytoplasmic RE complexes from breast tumor, fibroid, myometrial, and endometrial preparations but does not react with nuclear RE from human endometrium or cytoplasmic RE from other species tested. Conversely, antibody C3 (Class IgM) precipitates human cytoplasmic RE and nuclear RE complexes as well as labeled cytoplasmic RE from rat and calf uterus and chick oviduct. Neither antibody reacts with progesterone receptor or androgen receptor from human breast tumor, SHBG from human plasma, or rat alpha-fetoprotein. With D5, steroid labeling of cytoplasmic RE at 25 degrees increased the RE immune complex precipitated. D5 precipitates molybdate-stabilized RE from myometrial cytosol when labeled at 25 degrees but not at 4 degrees. C5 precipitates molybdate-stabilized RE whether cytosol was steroid-labeled at 4 degrees or 25 degrees. For D5, optimal precipitation of RE from human breast tumor was observed when cytosol was steroid-labeled at 25 degrees in buffers of pH range 5 to 6. Immunochemical studies indicate that D5 is associated with a Mr 29,000 component in RE-positive cytosols. Electrofocusing and sucrose density gradient analysis confirmed that D5 antigen is a non-hormone-binding component related to cytosolic RE from breast tumor and myometrium.

摘要

用通过亲和层析从人子宫肌层纯化的1至3微克细胞质雌激素受体片段对小鼠进行免疫。从一次融合中检测到两个分泌RE抗体的克隆,它们能够沉淀胞质溶胶RE。单克隆抗体D5(亚类IgG1)与一种抗原发生反应,该抗原在免疫沉淀研究中与RE相关,但可与激素结合单位分离。在抗小鼠血清存在下,D5从乳腺肿瘤、纤维瘤、子宫肌层和子宫内膜制剂中沉淀标记的人细胞质RE复合物,但不与人子宫内膜的核RE或所测试的其他物种的细胞质RE发生反应。相反,抗体C3(IgM类)沉淀人细胞质RE和核RE复合物以及来自大鼠和小牛子宫及鸡输卵管的标记细胞质RE。这两种抗体均不与人乳腺肿瘤中的孕酮受体或雄激素受体、人血浆中的SHBG或大鼠甲胎蛋白发生反应。使用D5时,25℃下细胞质RE的类固醇标记增加了沉淀的RE免疫复合物。当在25℃而非4℃标记时,D5从子宫肌层胞质溶胶中沉淀钼酸盐稳定的RE。无论胞质溶胶在4℃还是25℃进行类固醇标记,C5都能沉淀钼酸盐稳定的RE。对于D5,当胞质溶胶在pH范围为5至6的缓冲液中于25℃进行类固醇标记时,观察到从人乳腺肿瘤中RE的最佳沉淀。免疫化学研究表明,D5与RE阳性胞质溶胶中一个分子量为29,000的成分相关。电聚焦和蔗糖密度梯度分析证实,D5抗原是一种与乳腺肿瘤和子宫肌层的胞质溶胶RE相关的非激素结合成分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验